Evidence map›Paper›PMID 40995147›Full record

ArticleAPL bioengineering2025

Machine learning-enabled detection of electrophysiological signatures in iPSC-derived models of schizophrenia and bipolar disorder.

Kai Cheng, Autumn Williams, Anannya Kshirsagar, Sai Kulkarni, Rakesh Karmacharya, Deok-Ho Kim, Sridevi V Sarma, Annie Kathuria

Abstract read
In one paragraph

Article in APL bioengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Multi-Region Brain Organoids Integrating Cerebral, Mid-Hindbrain, and Endothelial Systems.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kai ChengDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland 21218, USA.ORCID https://orcid.org/0000-0002-9400-7507
Autumn WilliamsDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland 21218, USA.ORCID https://orcid.org/0000-0003-4660-1162
Anannya KshirsagarKrieger School of Arts and Sciences, Johns Hopkins University, Baltimore, Maryland 21218, USA.ORCID https://orcid.org/0009-0009-7519-3226
Sai KulkarniKrieger School of Arts and Sciences, Johns Hopkins University, Baltimore, Maryland 21218, USA.ORCID https://orcid.org/0009-0008-6185-1657
Sridevi V Sarma

Funding

Ex vivo signature of psychosis and treatment response in patient-derived neuronsR01MH113858 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI KARMACHARYA, RAKESH · 2017 to 2021
$2.7M
High-throughput neurovascular-unit-on-a-chip with OASIS for modeling Parkinson's diseaseR01NS133965 · NINDS · JOHNS HOPKINS UNIVERSITY · PI Deok-Ho Kim, Gabsang Lee · 2024 to 2026
$1.8M
Wnt/GSK3/beta Catenin Signaling as a Target for Treatment of Bipolar DisorderK08MH086846 · NIMH · MCLEAN HOSPITAL · PI KARMACHARYA, RAKESH · 2010 to 2014
$901k
NIMH NIH HHS K08 MH086846NIMH NIH HHS R01 MH113858NINDS NIH HHS R01 NS133965
6 · The paper itself

Abstract

Neuropsychiatric disorders such as schizophrenia (SCZ) and bipolar disorder (BPD) remain challenging to diagnose due to the absence of objective biomarkers, with current assessments relying largely on subjective clinical evaluations. In this study, we present a computational analysis pipeline designed to identify disease-specific electrophysiological signatures from multi-electrode array (MEA) recordings of patient-derived cerebral organoids (COs) and two-dimensional cortical interneuron cultures (2DNs). Using a Support Vector Machine classifier optimized for high-dimensional data, we achieved 95.8% classification accuracy in distinguishing SCZ from control samples in 2DNs under both baseline and post-electrical-stimulation (PES) conditions with the extracted electrophysiological signatures. In COs, classification accuracy improved from 83.3% at baseline to 91.6% following PES, enabling robust separation of control, SCZ, and BPD cohorts. Key discriminative features included channel-specific measures of network activity, with PES significantly enhancing classification performance, particularly for BPD. These results underscore the potential of MEA-based functional phenotyping, coupled with machine learning, to uncover reliable, stimulation-sensitive electrophysiological biomarkers, offering a path toward more objective diagnosis and personalized treatment strategies for neuropsychiatric disorders.

Identifiers

PMID40995147
PMCPMC12456967

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.